Annual Long Term Liabilities:
$0.00-$67.00K(-100.00%)Summary
- As of today, ELVN annual total long term liabilities is $0.00, with the most recent change of -$67.00 thousand (-100.00%) on December 31, 2024.
- During the last 3 years, ELVN annual long term liabilities has fallen by -$150.46 million (-100.00%).
- ELVN annual long term liabilities is now -100.00% below its all-time high of $150.46 million, reached on December 31, 2021.
Performance
ELVN Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Long Term Liabilities:
$103.00K-$101.00K(-49.51%)Summary
- As of today, ELVN quarterly total long term liabilities is $103.00 thousand, with the most recent change of -$101.00 thousand (-49.51%) on September 30, 2025.
- Over the past year, ELVN quarterly long term liabilities has increased by +$103.00 thousand (+100.00%).
- ELVN quarterly long term liabilities is now -99.93% below its all-time high of $150.56 million, reached on September 30, 2022.
Performance
ELVN Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ELVN Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -100.0% | +100.0% |
| 3Y3 Years | -100.0% | -99.9% |
| 5Y5 Years | -100.0% | -38.3% |
ELVN Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -100.0% | at low | -99.9% | >+9999.0% |
| 5Y | 5-Year | -100.0% | at low | -99.9% | >+9999.0% |
| All-Time | All-Time | -100.0% | at low | -99.9% | >+9999.0% |
ELVN Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $103.00K(-49.5%) |
| Jun 2025 | - | $204.00K(-32.5%) |
| Mar 2025 | - | $302.00K(>+9900.0%) |
| Dec 2024 | $0.00(-100.0%) | $0.00(0.0%) |
| Sep 2024 | - | $0.00(-100.0%) |
| Jun 2024 | - | $6000.00(-82.4%) |
| Mar 2024 | - | $34.00K(-49.3%) |
| Dec 2023 | $67.00K(-100.0%) | $67.00K(-68.7%) |
| Sep 2023 | - | $214.00K(-40.6%) |
| Jun 2023 | - | $360.00K(-29.1%) |
| Mar 2023 | - | $508.00K(-99.7%) |
| Dec 2022 | $150.41M | $150.41M(-0.1%) |
| Sep 2022 | - | $150.56M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $0.00(-100.0%) |
| Mar 2022 | - | $1.97M(-98.7%) |
| Dec 2021 | $150.46M(+0.4%) | - |
| Dec 2021 | - | $150.46M(>+9900.0%) |
| Sep 2021 | - | $466.00K(-11.7%) |
| Jun 2021 | - | $528.00K(-10.5%) |
| Mar 2021 | - | $590.00K(+268.8%) |
| Dec 2020 | $149.83M(>+9900.0%) | $160.00K(-4.2%) |
| Sep 2020 | - | $167.00K(-3.5%) |
| Jun 2020 | - | $173.00K(-3.4%) |
| Mar 2020 | - | $179.00K |
| Dec 2019 | $184.00K(>+9900.0%) | - |
| Dec 2018 | $0.00(-100.0%) | - |
| Dec 2017 | $660.00K | - |
FAQ
- What is Enliven Therapeutics, Inc. annual total long term liabilities?
- What is the all-time high annual long term liabilities for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. annual long term liabilities year-on-year change?
- What is Enliven Therapeutics, Inc. quarterly total long term liabilities?
- What is the all-time high quarterly long term liabilities for Enliven Therapeutics, Inc.?
- What is Enliven Therapeutics, Inc. quarterly long term liabilities year-on-year change?
What is Enliven Therapeutics, Inc. annual total long term liabilities?
The current annual long term liabilities of ELVN is $0.00
What is the all-time high annual long term liabilities for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high annual total long term liabilities is $150.46M
What is Enliven Therapeutics, Inc. annual long term liabilities year-on-year change?
Over the past year, ELVN annual total long term liabilities has changed by -$67.00K (-100.00%)
What is Enliven Therapeutics, Inc. quarterly total long term liabilities?
The current quarterly long term liabilities of ELVN is $103.00K
What is the all-time high quarterly long term liabilities for Enliven Therapeutics, Inc.?
Enliven Therapeutics, Inc. all-time high quarterly total long term liabilities is $150.56M
What is Enliven Therapeutics, Inc. quarterly long term liabilities year-on-year change?
Over the past year, ELVN quarterly total long term liabilities has changed by +$103.00K (+100.00%)